outcomes in progressive large b-cell lymphomas following cd19-specific car t cells
Published 5 years ago • 268 plays • Length 2:23Download video MP4
Download video MP3
Similar videos
-
48:12
outcomes of patients with aggressive b-cell lymphoma after failure of anti-cd19 car t-cell therapy
-
0:54
next steps for car t cells in b-cell lymphomas
-
2:37
efficacy of bispecific cd19/cd22 car t-cells in b-cell malignancies
-
3:20
outcomes for patients with disease progression following cd19-specific car t-cell therapy
-
45:46
cd19 targeted car t-cell therapy in lbcl
-
4:05
risk factors to predict post-cd19 car-t cell therapy outcomes in patients with lbcl
-
55:58
role of cd19 car t cells in second line large b cell lymphoma
-
40:48
car t cells in b-cell lymphoma: implications of new data and new therapy
-
6:55
potential for car t-cell therapy in b-cell lymphomas
-
2:13
tafasitamab plus lenalidomide post-cd19 car-t is associated with poor outcomes in lbcl
-
50:48
relapsed/refractory b-cell lymphomas in the car-t era: improving outcomes in a population at need
-
8:33
cd19-targeted car t-cell therapy in managing dlbcl
-
6:13
lymphoma: overview of chimeric antigen receptor (car) t cells
-
2:10
anti-cd20/19 car-t cell therapy in r/r b-cell malignancies
-
1:59
the importance of assessing response to cd19 car-t therapy in lbcl to confirm disease persistence
-
1:01
findings for cd19-targeted car t cells in combination with ibrutinib in cll
-
1:24
reverse fate mapping of car-t cells in patients with large b-cell lymphoma
-
36:51
dr glenn kennedy: car-t cell therapy and its relevance to lymphoma
-
0:36
how successful is car-t for b-cell lymphoma?